Autonomic dysfunction in Alzheimer's disease : tools for assessment and review of the literature
Autonomic dysfunction is very common in patients with dementia, and its presence might also help in differential diagnosis among dementia subtypes. Various central nervous system structures affected in Alzheimer's disease are also implicated in autonomic nervous system regulation, and it has been hypothesized that the deficit in central cholinergic function observed in Alzheimer's disease could likely lead to autonomic dysfunction. Several feasible tests can be used in clinical practice for the assessment of parasympathetic and sympathetic functions, especially in terms of cardiovascular autonomic modulation. In this review, we describe the different tests available and the evidence from the literature which indicate a definite presence of autonomic dysfunction in dementia at various degrees. Importantly, the recognition of dysautonomia, besides possibly being an early marker of dementia, would help prevent the disabling complications which increase the risk of morbidity, institutionalization, and mortality in these individuals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of Alzheimer's disease : JAD - 42(2014), 2 vom: 14., Seite 369-77 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Femminella, Grazia Daniela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alzheimer's disease |
|---|
| Anmerkungen: |
Date Completed 20.07.2015 Date Revised 08.04.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3233/JAD-140513 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM238889416 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM238889416 | ||
| 003 | DE-627 | ||
| 005 | 20231224114748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3233/JAD-140513 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0796.xml |
| 035 | |a (DE-627)NLM238889416 | ||
| 035 | |a (NLM)24898649 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Femminella, Grazia Daniela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autonomic dysfunction in Alzheimer's disease |b tools for assessment and review of the literature |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.07.2015 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Autonomic dysfunction is very common in patients with dementia, and its presence might also help in differential diagnosis among dementia subtypes. Various central nervous system structures affected in Alzheimer's disease are also implicated in autonomic nervous system regulation, and it has been hypothesized that the deficit in central cholinergic function observed in Alzheimer's disease could likely lead to autonomic dysfunction. Several feasible tests can be used in clinical practice for the assessment of parasympathetic and sympathetic functions, especially in terms of cardiovascular autonomic modulation. In this review, we describe the different tests available and the evidence from the literature which indicate a definite presence of autonomic dysfunction in dementia at various degrees. Importantly, the recognition of dysautonomia, besides possibly being an early marker of dementia, would help prevent the disabling complications which increase the risk of morbidity, institutionalization, and mortality in these individuals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Alzheimer's disease | |
| 650 | 4 | |a autonomic nervous system | |
| 650 | 4 | |a baroreflex | |
| 650 | 4 | |a functional recovery | |
| 650 | 4 | |a orthostatic hypotension | |
| 700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Komici, Klara |e verfasserin |4 aut | |
| 700 | 1 | |a Iacotucci, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Petraglia, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Pagano, Gennaro |e verfasserin |4 aut | |
| 700 | 1 | |a de Lucia, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Canonico, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Bonaduce, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Leosco, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrara, Nicola |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Alzheimer's disease : JAD |d 1998 |g 42(2014), 2 vom: 14., Seite 369-77 |w (DE-627)NLM097527327 |x 1875-8908 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2014 |g number:2 |g day:14 |g pages:369-77 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3233/JAD-140513 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2014 |e 2 |b 14 |h 369-77 | ||